What Is Senolytic
There is a family of tiny compounds known as senolytics that are now the subject of fundamental study to establish whether or not they may selectively trigger cell death in senescent cells and enhance human health. This study aims to find or create treatments that may postpone the onset of age-related disorders, prevent them, relieve their symptoms, or even reverse their effects. The term “senostatic,” which meaning to inhibit senescence, is one that is associated with this idea.
How You Will Benefit
(I) Insights, and validations about the following topics:
Chapter 1: Senolytic
Chapter 2: Life extension
Chapter 3: Dasatinib
Chapter 4: p16
Chapter 5: CGK733 fraud
Chapter 6: Bcl-xL
Chapter 7: Chromatin remodeling
Chapter 8: Telomerase reverse transcriptase
Chapter 9: ID1
Chapter 10: Cellular senescence
Chapter 11: Fisetin
Chapter 12: NKG2D
Chapter 13: Human umbilical vein endothelial cell
Chapter 14: Genetics of aging
Chapter 15: Navitoclax
Chapter 16: Senotherapy
Chapter 17: ABT-737
Chapter 18: Senescence-associated secretory phenotype
Chapter 19: Hallmarks of aging
Chapter 20: Timeline of senescence research
Chapter 21: Laura Niedernhofer
(II) Answering the public top questions about senolytic.
(III) Real world examples for the usage of senolytic in many fields.
(IV) 17 appendices to explain, briefly, 266 emerging technologies in each industry to have 360-degree full understanding of senolytic' technologies.
Who This Book Is For
Professionals, undergraduate and graduate students, enthusiasts, hobbyists, and those who want to go beyond basic knowledge or information for any kind of senolytic.
